Date: 2015-06-29
Type of information: Loan
Company: Sarepta Therapeutics (USA - MA)
Investors: Midcap Financial (USA - MD)
Amount: $40 million
Funding type: loan
Planned used:
Others: * On June 29, 2015, Sarepta Therapeutics announced that it entered into a credit and security agreement with Midcap Financial, a middle market-focused, specialty finance firm, that establishes a senior secured term loan facility that allows Sarepta to borrow up to $40,000,000 at an annual rate of 7.75%, with a maturity of June 2018, subject to certain conditions and other applicable fees. Sarepta has drawn down $20,000,000 under the facility and has the right to repay all borrowed funds and terminate the facility at any time.
Therapeutic area: Rare diseases - Genetic diseases - Neuromuscular diseases
